StockData
XTL Biopharmaceuticals Ltd logo

XTL Biopharmaceuticals Ltd (XTLB) stock

XTLBNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 30, 2026Score 0/30
$1.60−0.04 (-2.44%)

Close on Nov 13, 2026Market cap $15.14MP/E –Yield –

Earnings

XTL Biopharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of XTL Biopharmaceuticals's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

XTL Biopharmaceuticals has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When XTL Biopharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases XTL Biopharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K

  1. PRESS RELEASE DATED JUNE 30, 2026
    6-K
  2. PRESS RELEASE DATED MAY 22, 2026
    6-K
  3. NOTICE AND PROXY STATEMENT WITH RESPECT TO THE COMPANY'S EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
    6-K
  4. PROXY CARD FOR HOLDERS OF ORDINARY SHARES WITH RESPECT TO THE COMPANY'S EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
    6-K
  5. FORM OF SHARE PURCHASE AGREEMENT, BY AND AMONG XTL BIOPHARMACEUTICALS LTD. AND THE CURRENT SHAREHOLDERS OF PSYGA BIO LTD
    6-K
  6. PRESS RELEASE ISSUED APRIL 29, 2026
    6-K
  7. PRESS RELEASE DATED MARCH 20, 2026
    6-K
  8. PRESS RELEASE DATED FEBRUARY 27, 2026
    6-K
  9. PRESS RELEASE DATED JANUARY 23, 2026
    6-K
  10. NOTICE AND PROXY STATEMENT WITH RESPECT TO THE COMPANY'S EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
    6-K
  11. PROXY CARD FOR HOLDERS OF ORDINARY SHARES WITH RESPECT TO THE COMPANY'S EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
    6-K
  12. PRESS RELEASE DATED DECEMBER 24, 2025
    6-K
  13. NOTICE AND PROXY STATEMENT WITH RESPECT TO THE COMPANY'S ANNUAL AND EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
    6-K
  14. PROXY CARD FOR HOLDERS OF ORDINARY SHARES WITH RESPECT TO THE COMPANY'S ANNUAL AND EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
    6-K
  15. PRESS RELEASE DATED APRIL 7, 2025
    6-K

See a number that looks wrong?